Novavax Inc (NVAX)
Healthcare
Biotechnology
7.30 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -172 | -40 | -177 | -84 | 314 | -145 | -173 | -186 | -127 | 108 | -39 | -32 | -92 | |
| 10 | 11 | 11 | 12 | 11 | 13 | 13 | 8.3 | 7.6 | 6.6 | 5.1 | 3.1 | 22 | |
| 20 | 21 | 16 | 12 | 14 | 12 | 10 | 10 | 9.2 | 8.5 | 8.0 | 7.7 | 33 | |
| 51 | 36 | – | – | – | – | – | – | – | – | – | – | – | |
| -291 | 44 | -50 | 34 | 115 | -52 | -49 | -740 | -240 | 166 | -74 | -25 | -173 | |
| 7.8 | 18 | 9.1 | 7.3 | 3.1 | 2.0 | 2.3 | 1.6 | 0.2 | 2.0 | 2.1 | 1.3 | 5.6 | |
| -7.8 | -18 | -9.1 | -7.3 | -373 | 32 | 144 | -73 | 111 | -137 | 20 | -28 | -33 | |
| – | – | – | – | – | – | – | – | -5.3 | 0.8 | -0.3 | -8.2 | -13 | |
| -0.5 | 1.8 | – | – | – | -0.5 | -2.8 | -2.2 | -0.6 | 42 | -6.3 | 46 | 81 | |
| 61 | 197 | 100 | 5.9 | 258 | -0.1 | -3.4 | -7.1 | -1.0 | 42 | -6.6 | 38 | 72 | |
| -119 | 148 | -83 | -88 | 200 | -107 | -43 | -267 | -9.5 | 14 | -27 | -23 | -46 | |
| -180 | -58 | -186 | -91 | 311 | -147 | -175 | -187 | -128 | 106 | -42 | -34 | -97 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.